UNIVERSI
TÄ
TS-
BIBLIOTHEK
P
ADERBORN
Anmelden
Menü
Menü
Start
Hilfe
Blog
Weitere Dienste
Neuerwerbungslisten
Fachsystematik Bücher
Erwerbungsvorschlag
Bestellung aus dem Magazin
Fernleihe
Einstellungen
Sprache
Deutsch
Deutsch
Englisch
Farbschema
Hell
Dunkel
Automatisch
Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist
gegebenenfalls
nur via VPN oder Shibboleth (DFN-AAI) möglich.
mehr Informationen...
Universitätsbibliothek
Katalog
Suche
Details
Zur Ergebnisliste
Ergebnis 10 von 32
Datensatz exportieren als...
BibTeX
A local application of recombinant human fibroblast growth factor 2 for tibial shaft fractures: A randomized, placebo‐controlled trial
Journal of bone and mineral research, 2010-12, Vol.25 (12), p.2735-2743
Kawaguchi, Hiroshi
Oka, Hiroyuki
Jingushi, Seiya
Izumi, Toshihiro
Fukunaga, Masao
Sato, Katsumi
Matsushita, Takashi
Nakamura, Kozo
2010
Volltextzugriff (PDF)
Details
Autor(en) / Beteiligte
Kawaguchi, Hiroshi
Oka, Hiroyuki
Jingushi, Seiya
Izumi, Toshihiro
Fukunaga, Masao
Sato, Katsumi
Matsushita, Takashi
Nakamura, Kozo
Titel
A local application of recombinant human fibroblast growth factor 2 for tibial shaft fractures: A randomized, placebo‐controlled trial
Ist Teil von
Journal of bone and mineral research, 2010-12, Vol.25 (12), p.2735-2743
Ort / Verlag
Hoboken: Wiley Subscription Services, Inc., A Wiley Company
Erscheinungsjahr
2010
Quelle
Electronic Journals Library
Beschreibungen/Notizen
Fibroblast growth factor 2 (FGF‐2) is a potent mitogen for mesenchymal cells, and a local application of recombinant human FGF‐2 (rhFGF‐2) in a gelatin hydrogel has been reported to accelerate bone union in our animal studies and preparatory dose‐escalation trial on patients with surgical osteotomy. We have performed a randomized, double‐blind, placebo‐controlled trial in which patients with fresh tibial shaft fractures of transverse or short oblique type were randomly assigned to three groups receiving a single injection of the gelatin hydrogel containing either placebo or 0.8 mg (low‐dosage group) or 2.4 mg (high‐dosage group) of rhFGF‐2 into the fracture gap at the end of an intramedullary nailing surgery. Of 194 consecutive patients over 2 years, 85 met the eligibility criteria, and 70 (24 in the placebo group and 23 each in low‐ and high‐dosage groups) completed the 24‐week study. The cumulative percentages of patients with radiographic bone union were higher in the rhFGF‐2‐treated groups (p = .031 and .009 in low‐ and high‐dosage group, respectively) compared with the placebo group, although there was no significant difference between low‐ and high‐dosage groups (p = .776). At 24 weeks, 4, 1, and 0 patients in the placebo, low‐dosage, and high‐dosage groups, respectively, continued to show delayed union. No patient underwent a secondary intervention, and the time to full weight bearing without pain was not significantly different among the three groups (p = .567). There also was no significant difference in the profiles of adverse events among the groups. In conclusion, a local application of the rhFGF‐2 hydrogel accelerated healing of tibial shaft fractures with a safety profile. © 2010 American Society for Bone and Mineral Research.
Sprache
Englisch
Identifikatoren
ISSN: 0884-0431
eISSN: 1523-4681
DOI: 10.1002/jbmr.146
Titel-ID: cdi_proquest_miscellaneous_851471196
Format
–
Schlagworte
Adult
,
Antibodies - blood
,
Biological and medical sciences
,
CLINICAL TRIAL
,
Diabetes Complications - blood
,
Female
,
FIBROBLAST GROWTH FACTOR
,
Fibroblast Growth Factor 2 - administration & dosage
,
Fibroblast Growth Factor 2 - adverse effects
,
Fibroblast Growth Factor 2 - blood
,
Fibroblast Growth Factor 2 - therapeutic use
,
FRACTURE HEALING
,
Fundamental and applied biological sciences. Psychology
,
Humans
,
Kaplan-Meier Estimate
,
Male
,
Middle Aged
,
Multivariate Analysis
,
Placebos
,
Radiography
,
Recombinant Proteins - administration & dosage
,
Recombinant Proteins - adverse effects
,
Recombinant Proteins - blood
,
Recombinant Proteins - therapeutic use
,
Skeleton and joints
,
Tibial Fractures - blood
,
Tibial Fractures - complications
,
Tibial Fractures - diagnostic imaging
,
Tibial Fractures - drug therapy
,
Vertebrates: osteoarticular system, musculoskeletal system
Weiterführende Literatur
Empfehlungen zum selben Thema automatisch vorgeschlagen von
bX